Akin O, Lema-Dopico A, Paudyal R, Konar A, Chenevert T, Malyarenko D
Cancers (Basel). 2023; 15(22).
PMID: 38001728
PMC: 10670574.
DOI: 10.3390/cancers15225468.
Wang Y, Chen S, Zhang W, Xiao W, Su J, Zhang R
Quant Imaging Med Surg. 2023; 13(4):2526-2537.
PMID: 37064386
PMC: 10102749.
DOI: 10.21037/qims-22-851.
Li L, Zhang J, Zhe X, Chang H, Tang M, Lei X
Front Oncol. 2023; 13:1025972.
PMID: 37007156
PMC: 10060523.
DOI: 10.3389/fonc.2023.1025972.
Nakagawa R, Izumi K, Naito R, Kadomoto S, Iwamoto H, Yaegashi H
Cancers (Basel). 2022; 14(23).
PMID: 36497249
PMC: 9737124.
DOI: 10.3390/cancers14235767.
Fu W, Liu D, Xiong Y, Liu C, Liu J, Yi X
Int Urol Nephrol. 2022; 55(5):1073-1079.
PMID: 36422743
DOI: 10.1007/s11255-022-03410-2.
Role of multiparametric magnetic resonance imaging in the diagnosis and staging of urinary bladder cancer.
Shalaby E, Mohamed A, Elkammash T, Abouelkheir R, Housseini A
Curr Urol. 2022; 16(3):127-135.
PMID: 36204360
PMC: 9527936.
DOI: 10.1097/CU9.0000000000000128.
Diffusion-weighted magnetic resonance imaging in bladder cancer: comparison of readout-segmented and single-shot EPI techniques.
Chen H, Chen L, Liu F, Lu J, Xu C, Wang L
Cancer Imaging. 2019; 19(1):59.
PMID: 31455403
PMC: 6712649.
DOI: 10.1186/s40644-019-0245-1.
Evaluation of lymph node status in patients with urothelial carcinoma-still in search of the perfect imaging modality: a systematic review.
Fraczek M, Kamecki H, Kamecka A, Sosnowski R, Sklinda K, Czarniecki M
Transl Androl Urol. 2018; 7(5):783-803.
PMID: 30456182
PMC: 6212628.
DOI: 10.21037/tau.2018.08.28.
ICUD-SIU International Consultation on Bladder Cancer 2017: management of non-muscle invasive bladder cancer.
Monteiro L, Witjes J, Agarwal P, Anderson C, Bivalacqua T, Bochner B
World J Urol. 2018; 37(1):51-60.
PMID: 30109483
DOI: 10.1007/s00345-018-2438-9.
Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancer.
Fernandez M, Brausi M, Clark P, Cookson M, Grossman H, Khochikar M
World J Urol. 2018; 37(1):3-13.
PMID: 30105454
DOI: 10.1007/s00345-018-2436-y.
Diffusion weighted magnetic resonance imaging in bladder cancer, is it time to replace biopsy?.
Al Johi R, Seifeldein G, Moeen A, Aboulhagag N, Moussa E, Hameed D
Cent European J Urol. 2018; 71(1):31-37.
PMID: 29732204
PMC: 5926631.
DOI: 10.5173/ceju.2017.1427.
Bladder cancer: detection and image quality compared among iShim, RESOLVE, and ss-EPI diffusion-weighted MR imaging with high b value at 3.0 T MRI.
Li H, Liu L, Shi Q, Stemmer A, Zeng H, Li Y
Medicine (Baltimore). 2018; 96(50):e9292.
PMID: 29390388
PMC: 5815800.
DOI: 10.1097/MD.0000000000009292.
Differentiation between high- and low-grade urothelial carcinomas using contrast enhanced ultrasound.
Li Q, Tang J, He E, Li Y, Zhou Y, Wang B
Oncotarget. 2017; 8(41):70883-70889.
PMID: 29050329
PMC: 5642604.
DOI: 10.18632/oncotarget.20151.
Apparent diffusion coefficient on magnetic resonance imaging (MRI) in bladder cancer: relations with recurrence/progression risk.
Kikuchi K, Shigihara T, Hashimoto Y, Miyajima M, Haga N, Kojima Y
Fukushima J Med Sci. 2017; 63(2):90-99.
PMID: 28680010
PMC: 5597528.
DOI: 10.5387/fms.2017-05.
Radiomics assessment of bladder cancer grade using texture features from diffusion-weighted imaging.
Zhang X, Xu X, Tian Q, Li B, Wu Y, Yang Z
J Magn Reson Imaging. 2017; 46(5):1281-1288.
PMID: 28199039
PMC: 5557707.
DOI: 10.1002/jmri.25669.
Non-contrast magnetic resonance imaging for bladder cancer: fused high b value diffusion-weighted imaging and T2-weighted imaging helps evaluate depth of invasion.
Lee M, Shin S, Oh Y, Jung D, Cho N, Choi Y
Eur Radiol. 2017; 27(9):3752-3758.
PMID: 28168374
DOI: 10.1007/s00330-017-4759-2.
Plasmacytoid urothelial carcinoma (PUC): Imaging features with histopathological correlation.
Chung A, Schieda N, Flood T, Cagiannos I, Mai K, Malone S
Can Urol Assoc J. 2017; 11(1-2):E50-E57.
PMID: 28163816
PMC: 5262514.
DOI: 10.5489/cuaj.3789.
Non-invasive quantification of tumour heterogeneity in water diffusivity to differentiate malignant from benign tissues of urinary bladder: a phase I study.
Nguyen H, Shah Z, Mortazavi A, Pohar K, Wei L, Jia G
Eur Radiol. 2016; 27(5):2146-2152.
PMID: 27553924
PMC: 5613982.
DOI: 10.1007/s00330-016-4549-2.
Cross-sectional imaging of complicated urinary infections affecting the lower tract and male genital organs.
Tonolini M, Ippolito S
Insights Imaging. 2016; 7(5):689-711.
PMID: 27271509
PMC: 5028337.
DOI: 10.1007/s13244-016-0503-8.
Nonmuscle-invasive and Muscle-invasive Urinary Bladder Cancer: Image Quality and Clinical Value of Reduced Field-of-view Versus Conventional Single-shot Echo-planar Imaging DWI.
Wang Y, Li Z, Meng X, Hu X, Shen Y, Morelli J
Medicine (Baltimore). 2016; 95(10):e2951.
PMID: 26962794
PMC: 4998875.
DOI: 10.1097/MD.0000000000002951.